Cytoreductive nephrectomy in the elderly: A population-based cohort from the USA

BJU International

Volumn 109, Issue 12, 2012, Pages 1807-1812

  Sun, Maxine ^a   Abdollah, Firas ^a,b   Schmitges, Jan ^a,c   Bianchi, Marco ^a,b   Tian, Zhe ^a   Shariat, Shahrokh F ^d   Zorn, Kevin ^a   Pharand, Daniel ^a   Widmer, Hugues ^a   Graefen, Markus ^c   Montorsi, Francesco ^b   Perrotte, Paul ^a   Karakiewicz, Pierre I ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

^b VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^c UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^d WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

complications; cytoreductive nephrectomy; elderly; metastatic renal cell carcinoma; morbidity; perioperative mortality

Indexed keywords

AGE; AGED; AMERICAN INDIAN; ARTICLE; ASIAN; BLOOD TRANSFUSION; CAUCASIAN; COHORT ANALYSIS; COMORBIDITY; CYTOREDUCTIVE NEPHRECTOMY; CYTOREDUCTIVE SURGERY; ELDERLY CARE; FEMALE; GASTROINTESTINAL DISEASE; HEART DISEASE; HISPANIC; HUMAN; KIDNEY CARCINOMA; LENGTH OF STAY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; METASTASIS POTENTIAL; MULTIVARIATE ANALYSIS; NEGRO; PACIFIC ISLANDER; PEROPERATIVE COMPLICATION; POPULATION RESEARCH; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; RACE DIFFERENCE; RESPIRATORY TRACT DISEASE; SEROMA; SEX DIFFERENCE; SURGICAL INFECTION; SURGICAL MORTALITY; TREATMENT OUTCOME; UNITED STATES;

AGED; AGED, 80 AND OVER; CARCINOMA, RENAL CELL; COHORT STUDIES; FEMALE; HUMANS; INTRAOPERATIVE COMPLICATIONS; KIDNEY NEOPLASMS; LENGTH OF STAY; MALE; MIDDLE AGED; NEPHRECTOMY; POSTOPERATIVE COMPLICATIONS; TREATMENT OUTCOME; UNITED STATES;

EID: 84861571452     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2011.10569.x     Document Type: Article

References (17)

1. National Comprehensive Cancer Network (NCCN). NCCN clinical practice guidelines in oncology, Kidney Cancer, 2011: National Comprehensive Cancer Network. [Available at
2. Kader AK, Tamboli P, Luongo T, et al,. Cytoreductive nephrectomy in the elderly patient: the M. D. Anderson Cancer Center experience. J Urol 2007; 177: 855-60; discussion 860-1
3. Charlson ME, Pompei P, Ales KL, et al,. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987; 40: 373-83
4. Deyo RA, Cherkin D, Ciol M,. Adapting a clinical comorbidity index for use with ICD-9-CM administrative database. J Clin Epidemiol 1992; 45: 613-9
5. United States Census Bureau. Summary Social, economic, and housing characteristics. 2000.
6. Joudi FN, Allareddy V, Kane CJ, et al,. Analysis of complications following partial and total nephrectomy for renal cancer in a population based sample. J Urol 2007; 177: 1709-14
7. Mickisch GH, Garin A, Van Poppel H, et al,. Radical nephrectomy plus interferon-alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomised trial. Lancet 2001; 358: 966-70
8. Flanigan RC, Salmon SE, Blumenstein BA, et al,. Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer. N Engl J Med 2001; 345: 1655-9
9. Sun M, Lughezzani G, Perrotte P, et al,. Treatment of metastatic renal cell carcinoma. Nat Rev Urol 2010; 7: 327-38
10. Motzer RJ, Bacik J, Schwartz LH, et al,. Prognostic factors for survival in previously treated patients with metastatic renal cell carcinoma. J Clin Oncol 2004; 22: 454-63
11. Motzer RJ, Mazumdar M, Bacik J, et al,. Survival and prognostic stratification of 670 patients with advanced renal cell carcinoma. J Clin Oncol 1999; 17: 2530-40
12. EORTC. Randomized Phase III trial comparing immediate versus deferred nephrectomy in patients with synchronous metastatic renal cell carcinoma, EORTC protocol 30073-SURTIME. 2010
13. CARMENA. Randomized Phase III Trial Evaluating the Importance of Nephrectomy in Patients Presenting With Metastatic Renal Cell Carcinoma Treated With Sunitinib., Clinical trial to assess the importance of nephrectomy (CARMENA). 2010
14. Cloutier V, Capitanio U, Zini L, et al,. Thirty-day mortality after nephrectomy: clinical implications for informed consent. Eur Urol 2008; 56: 998-1003
15. Simmons MN, Gill IS,. Decreased complications of contemporary laparoscopic partial nephrectomy: use of a standardized reporting system. J Urol 2007; 177: 2067-73; discussion 2073
16. Nogueira L, Katz D, Pinochet R, et al,. Critical evaluation of perioperative complications in laparoscopic partial nephrectomy. Urology 2010; 75: 288-94
17. Shabsigh A, Korets R, Vora KC, et al,. Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. Eur Urol 2009; 55: 164-74